Cartesian Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 2.42 M | $43.40 M | -15.03% | 1.56% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 721,139 | $12.92 M | 14.57% | 0.46% |
BLACKROCK, INC. | 02/07/2025 | 659,402 | $11.81 M | 55.72% | 0.43% |
SIREN, L.L.C. | 02/14/2025 | 572,236 | $10.25 M | 0.00% | 0.37% |
CITADEL ADVISORS LLC | 02/14/2025 | 315,000 | $5.64 M | -16.17% | 0.20% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 221,257 | $3.96 M | 63.05% | 0.14% |
02/10/2025 | 173,566 | $3.26 M | 0.00% | 0.11% | |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 125,000 | $2.24 M | 65.71% | 0.08% |
NORTHERN TRUST CORP | 02/14/2025 | 95,030 | $1.70 M | 50.57% | 0.06% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 72,099 | $1.29 M | 197.81% | 0.05% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 52,166 | $934,294 | -0.05% | 0.03% |
FREESTONE CAPITAL HOLDINGS, LLC | 02/06/2025 | 25,921 | $464,245 | 0.00% | 0.02% |
MORGAN STANLEY | 02/14/2025 | 24,262 | $434,533 | 10.23% | 0.02% |
DELPHI FINANCIAL GROUP, INC. | 02/06/2025 | 22,028 | $394,521 | 0.00% | 0.01% |
ALPS ADVISORS INC | 02/13/2025 | 20,550 | $368,051 | 100.00% | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 14,491 | $259,534 | -0.19% | 0.01% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 13,800 | $247,158 | 100.00% | 0.01% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 02/13/2025 | 12,000 | $214,920 | 0.00% | 0.01% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 11,812 | $211,553 | -8.51% | 0.01% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 11,690 | $209,367 | 54.43% | 0.01% |
SQUAREPOINT OPS LLC | 02/14/2025 | 10,652 | $190,777 | 2.49% | 0.01% |
CITIGROUP INC | 02/12/2025 | 8,251 | $147,776 | 58.16% | 0.01% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 5,786 | $103,627 | 44.76% | 0.00% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 5,389 | $96,517 | 100.00% | 0.00% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 5,122 | $91,735 | 32.56% | 0.00% |
JOHNSON FINANCIAL GROUP, INC. | 02/14/2025 | 4,618 | $89,174 | 0.00% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 4,562 | $17,431 | 22.80% | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 3,902 | $70,000 | -23.52% | 0.00% |
VIRTUS ETF ADVISERS LLC | 02/14/2025 | 3,533 | $63,276 | 100.00% | 0.00% |
HALL LAURIE J TRUSTEE | 01/16/2025 | 1,759 | $32,000 | 0.00% | 0.00% |
02/11/2025 | 1,453 | $26,023 | 100.00% | 0.00% | |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 1,150 | $20,597 | 43.57% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 623 | $11,158 | 9.88% | 0.00% |
02/19/2025 | 534 | $9,564 | 100.00% | 0.00% | |
WR WEALTH PLANNERS, LLC | 02/05/2025 | 233 | $591 | 497.44% | 0.00% |
AMALGAMATED BANK | 02/04/2025 | 130 | $2,000 | 0.00% | 0.00% |
DAIWA SECURITIES GROUP INC. | 02/07/2025 | 84 | $2,000 | 100.00% | 0.00% |
ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 66 | $1,182 | 0.00% | 0.00% |
SPIRE WEALTH MANAGEMENT | 01/24/2025 | 50 | $896 | 100.00% | 0.00% |
02/06/2025 | 49 | $878 | 100.00% | 0.00% | |
NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 48 | $860 | 336.36% | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 40 | $716 | 100.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 18 | $322 | 0.00% | 0.00% |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 14 | $251 | 100.00% | 0.00% |
02/12/2025 | 10 | $180 | 100.00% | 0.00% | |
TRUVESTMENTS CAPITAL LLC | 02/10/2025 | 10 | $179 | 100.00% | 0.00% |
02/06/2025 | 6 | $107 | 100.00% | 0.00% | |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
YALE UNIVERSITY | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Cartesian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of Cartesian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 2.42 M
BioImpact Capital LLC: 721,139
BlackRock, Inc.: 659,402
Siren, L.L.C.: 572,236
CITADEL ADVISORS LLC: 315,000
GEODE CAPITAL MANAGEMENT, LLC: 221,257
4.19% of Cartesian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.88 M shares in the last 24 months. This purchase volume represents approximately $58.77 M in transactions.